On 7/15/2021 Jefferies Financial Group brokerage Boosted the Price Target from Positive to Hold from $170.00 to $250.00 On 5/7/2021 Morgan Stanley brokerage Lowered the Price Target to Equal Weight from $201.00 to $190.00 On 5/7/2021 The Goldman Sachs Group brokerage Boosted the Price Target to Buy from $206.00 to $228.00
My price target for MRNA is the Fib 0.382 level: 365usd
All the biopharma has a downtrend at the moment except dividend stocks
Usually it's a risky investment with potentially big upside
1 vaccine from temporary virus is not enough. I don't see any prospects in the company.
I would buy it for $20-30 as the biotechnology market
During the hype I see the stock moving to 300 (and filling the gap at 260) which is psychologically acceptable level. It doesn't have many short position to go higher than 400. All the shorts were squeezed at 500
Usually it's a risky investment with potentially big upside
1 vaccine from temporary virus is not enough. I don't see any prospects in the company.
I would buy it for $20-30 as the biotechnology market
During the hype I see the stock moving to 300 (and filling the gap at 260) which is psychologically acceptable level. It doesn't have many short position to go higher than 400. All the shorts were squeezed at 500